학술논문

Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.
Document Type
article
Source
Cancer cell. 26(1)
Subject
Cell Line
Tumor
Fibroblasts
Stromal Cells
Animals
Mice
Inbred C57BL
Mice
Knockout
Humans
Mice
Prostatic Intraepithelial Neoplasia
Prostatic Neoplasms
Cell Transformation
Neoplastic
Neoplasm Invasiveness
Prostatic Hyperplasia
Inflammation
Multiprotein Complexes
Glucose
Amino Acids
Adaptor Proteins
Signal Transducing
Proto-Oncogene Proteins c-myc
Heat-Shock Proteins
Inflammation Mediators
Interleukin-6
Coculture Techniques
Transfection
Cell Communication
Signal Transduction
RNA Interference
Energy Metabolism
Oxidative Stress
Time Factors
Male
PTEN Phosphohydrolase
HEK293 Cells
TOR Serine-Threonine Kinases
Tumor Microenvironment
Sequestosome-1 Protein
Mechanistic Target of Rapamycin Complex 1
Oncology & Carcinogenesis
Oncology and Carcinogenesis
Neurosciences
Language
Abstract
The tumor microenvironment plays a critical role in cancer progression, but the precise mechanisms by which stromal cells influence the epithelium are poorly understood. Here we show that p62 levels were reduced in the stroma of several tumors and that its loss in the tumor microenvironment or stromal fibroblasts resulted in increased tumorigenesis of epithelial prostate cancer cells. The mechanism involves the regulation of cellular redox through an mTORC1/c-Myc pathway of stromal glucose and amino acid metabolism, resulting in increased stromal IL-6 production, which is required for tumor promotion in the epithelial compartment. Thus, p62 is an anti-inflammatory tumor suppressor that acts through the modulation of metabolism in the tumor stroma.